Skip to main content
Livermore
Livermore
ZHEN

Redmile Group, LLC

SEC CIK
0001425738
Latest filing
Aug 14, 2026

Holdings in Q4 2023

Holdings as of Dec 31, 2023, filed Feb 14, 2024. Long positions only; changes compare share counts with Q3 2023.

Institution overview
Positions
70
+2 vs. Q3 2023
Portfolio value
$2.80B
+$694.2M (+33.0%) vs. Q3 2023
Filed
Feb 14, 2024
SEC
Holdings of Redmile Group, LLC in Q4 2023
SecurityClassSharesValue% of portfolioShare changeActionHistory
IMGNImmunoGen, Inc.COM16,423,922$487.0M17.4%−1,079,495−6.2%ReducedHistory
KRYSKrystal Biotech, Inc.COM1,733,189$215.0M7.7%−270,178−13.5%ReducedHistory
FOLDAmicus Therapeutics, Inc.COM14,828,321$210.4M7.5%−2,116,300−12.5%ReducedHistory
SRRKScholar Rock Holding CorpCOM6,402,505$120.4M4.3%+1,669,257+35.3%AddedHistory
RYZBRayzeBio, Inc.COM1,857,706$115.5M4.1%00.0%UnchangedHistory
AUGXAugmedix, Inc.COM16,380,327$95.8M3.4%+750,000+4.8%AddedHistory
DCPHDeciphera Pharmaceuticals, Inc.COM4,801,540$77.4M2.8%+326,156+7.3%AddedHistory
SPYSPDR S&P 500 ETF TrustETF142,500$67.7M2.4%+142,500NewHistory
RGNXREGENXBIO Inc.COM3,760,690$67.5M2.4%+1,186,648+46.1%AddedHistory
BHVNBiohaven Ltd.COM1,444,365$61.8M2.2%+925,441+178.3%AddedHistory
ZYMEZymeworks Inc.COM5,790,230$60.2M2.2%+129,000+2.3%AddedHistory
LIVNLivaNova PLCSHS1,137,068$58.8M2.1%+36,576+3.3%AddedHistory
ALXOAlx Oncology Holdings IncCOM3,659,264$54.5M1.9%+2,375,975+185.1%AddedHistory
CTLTCatalent, Inc.COM1,100,466$49.4M1.8%+226,500+25.9%AddedHistory
FATEFate Therapeutics IncCOM13,169,057$49.3M1.8%+44,630+0.3%AddedHistory
PLRXPliant Therapeutics, Inc.COM2,696,648$48.8M1.7%+18,549+0.7%AddedHistory
KYMRKymera Therapeutics, Inc.COM1,823,956$46.4M1.7%−44,551−2.4%ReducedHistory
IMNMImmunome Inc.COM3,879,415$41.5M1.5%+3,879,415NewHistory
IMVTImmunovant, Inc.COM977,072$41.2M1.5%−125,442−11.4%ReducedHistory
BSXBoston Scientific CorpStock693,200$40.1M1.4%−81,000−10.5%ReducedHistory
STTKShattuck Labs, Inc.COM5,619,914$40.1M1.4%00.0%UnchangedHistory
CLDXCelldex Therapeutics, Inc.COM NEW993,803$39.4M1.4%−642,135−39.3%ReducedHistory
BEAMBeam Therapeutics Inc.COM1,429,783$38.9M1.4%−39,942−2.7%ReducedHistory
ABSIAbsci CorpCOM8,031,094$33.7M1.2%00.0%UnchangedHistory
NRIXNurix Therapeutics, Inc.COM3,256,519$33.6M1.2%+407,692+14.3%AddedHistory
IDYAIDEAYA Biosciences, Inc.COM935,863$33.3M1.2%+935,863NewHistory
REPLReplimune Group, Inc.COM3,865,258$32.6M1.2%−298,664−7.2%ReducedHistory
CABACabaletta Bio, Inc.COM1,374,189$31.2M1.1%−400,063−22.5%ReducedHistory
ABTAbbott LaboratoriesStock265,500$29.2M1.0%+265,500NewHistory
EVHEvolent Health, Inc.CL A835,537$27.6M1.0%+370,255+79.6%AddedHistory
AKROAkero Therapeutics, Inc.COM1,109,476$25.9M0.9%−660,208−37.3%ReducedHistory
ADCTADC Therapeutics SASHS15,328,317$25.4M0.9%+1,150,272+8.1%AddedHistory
ANNXAnnexon, Inc.COM5,503,190$25.0M0.9%+2,000,000+57.1%AddedHistory
IGMSIGM Biosciences, Inc.COM2,971,542$24.7M0.9%00.0%UnchangedHistory
VERVVerve Therapeutics, Inc.COM1,718,669$24.0M0.9%+908,892+112.2%AddedHistory
PENPenumbra IncCOM95,242$24.0M0.9%−59,834−38.6%ReducedHistory
ETNB89bio, Inc.COM1,969,402$22.0M0.8%+1,207,447+158.5%AddedHistory
CRLCharles River Laboratories International, Inc.COM86,782$20.5M0.7%+20,400+30.7%AddedHistory
TRDAEntrada Therapeutics, Inc.COM1,283,735$19.4M0.7%−2650.0%ReducedHistory
NGNENeurogene Inc.COM946,897$18.4M0.7%+801,286+550.3%AddedConverted for a 1-for-4 splitHistory
ISRGIntuitive Surgical IncCOM NEW54,258$18.3M0.7%+54,258NewHistory
HCAHCA Healthcare, Inc.COM66,100$17.9M0.6%+41,433+168.0%AddedHistory
COGTCogent Biosciences, Inc.COM2,914,022$17.1M0.6%+860,689+41.9%AddedHistory
SYKStryker CorpStock53,141$15.9M0.6%−41,597−43.9%ReducedHistory
RPTXRepare Therapeutics Inc.COM2,148,748$15.7M0.6%−255,947−10.6%ReducedHistory
STOKStoke Therapeutics, Inc.COM2,625,506$13.8M0.5%−1,247,190−32.2%ReducedHistory
ALGNAlign Technology IncCOM50,082$13.7M0.5%+50,082NewHistory
GRTSGritstone bio, Inc.COM5,872,605$12.0M0.4%−2,636,521−31.0%ReducedHistory
PRMEPrime Medicine, Inc.COM1,324,350$11.7M0.4%00.0%UnchangedHistory
ELVElevance Health, Inc.Stock23,079$10.9M0.4%−62,299−73.0%ReducedHistory
ALLKAllakos Inc.COM3,670,447$10.0M0.4%−464,614−11.2%ReducedHistory
ACIUAC Immune SASHS2,000,000$10.0M0.4%+2,000,000NewHistory
RAPTRAPT Therapeutics, Inc.COM366,776$9.11M0.3%−60,714−14.2%ReducedHistory
STXSStereotaxis, Inc.COM NEW3,402,443$5.95M0.2%−2,363,349−41.0%ReducedHistory
IVVDInvivyd, Inc.COM1,440,725$5.68M0.2%00.0%UnchangedHistory
SNCEScience 37 Holdings, Inc.COM NEW990,412$5.29M0.2%00.0%UnchangedConverted for a 1-for-20 splitHistory
ATRAAtara Biotherapeutics, Inc.COM9,106,446$4.67M0.2%+2,825,633+45.0%AddedHistory
NUVBNuvation Bio Inc.COM CL A3,031,009$4.58M0.2%00.0%UnchangedHistory
LVTXLAVA Therapeutics NVSHS2,074,372$3.28M0.1%00.0%UnchangedHistory
MDVLMedAvail Holdings, Inc.COM NEW692,082$3.05M0.1%00.0%UnchangedHistory
XERSXeris Biopharma Holdings, Inc.COM1,046,587$2.46M0.1%00.0%UnchangedHistory
Achilles Therapeutics PLC00449L102SPONSORED ADS1,608,089$1.43M0.1%00.0%Unchanged–
KLRSKalaris Therapeutics, Inc.COM1,907,969$1.30M<0.1%00.0%UnchangedHistory
SLGCSomaLogic, Inc.CLASS A COM370,839$938.2K<0.1%−28,600−7.2%ReducedHistory
NVTAInvitae CorpCOM1,474,026$923.9K<0.1%−806,377−35.4%ReducedHistory
HOOKHOOKIPA Pharma Inc.COM1,063,769$861.7K<0.1%00.0%UnchangedHistory
TKNOAlpha Teknova, Inc.COM161,005$600.5K<0.1%−123,559−43.4%ReducedHistory
ADAPYAdaptimmune Therapeutics PLCSPONDS ADR715,607$567.5K<0.1%00.0%UnchangedHistory
VTYXVentyx Biosciences, Inc.COM207,203$511.8K<0.1%−722,697−77.7%ReducedHistory
BCELAtreca, Inc.CL A COM442,653$58.4K<0.1%00.0%UnchangedHistory

Sold out since Q3 2023 (5)

Positions held at the end of Q3 2023 that are gone from this filing.

Positions of Redmile Group, LLC sold out since Q3 2023
SecurityClassShares in Q3 2023Value in Q3 2023% of portfolio in Q3 2023History
HUMHumana IncStock59,851$29.1M1.4%History
DXCMDexcom IncCOM244,391$22.8M1.1%History
XENEXenon Pharmaceuticals Inc.COM419,568$14.3M0.7%History
CUTRCutera IncCOM334,996$2.02M0.1%History
SONXSonendo, Inc.COM410,393$306.1K<0.1%History